Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 650

1.

Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.

Taylor JW, Parikh M, Phillips JJ, James CD, Molinaro AM, Butowski NA, Clarke JL, Oberheim-Bush NA, Chang SM, Berger MS, Prados M.

J Neurooncol. 2018 Aug 27. doi: 10.1007/s11060-018-2977-3. [Epub ahead of print]

PMID:
30151703
2.

Subcortical stimulation mapping of descending motor pathways for perirolandic gliomas: assessment of morbidity and functional outcome in 702 cases.

Han SJ, Morshed RA, Troncon I, Jordan KM, Henry RG, Hervey-Jumper SL, Berger MS.

J Neurosurg. 2018 Aug 17:1-8. doi: 10.3171/2018.3.JNS172494. [Epub ahead of print]

PMID:
30117770
3.

5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.

Chohan MO, Berger MS.

J Neurooncol. 2018 Aug 10. doi: 10.1007/s11060-018-2956-8. [Epub ahead of print] Review.

PMID:
30097823
4.

Interfacility neurosurgical transfers: an analysis of nontraumatic inpatient and emergency department transfers with implications for improvements in care.

Safaee MM, Morshed RA, Spatz J, Sankaran S, Berger MS, Aghi MK.

J Neurosurg. 2018 Aug 3:1-9. doi: 10.3171/2018.3.JNS173224. [Epub ahead of print]

PMID:
30074453
5.

The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.

Phillips JJ, Gong H, Chen K, Joseph NM, van Ziffle J, Bastian BC, Grenert JP, Kline CN, Mueller S, Banerjee A, Nicolaides T, Gupta N, Berger MS, Lee HS, Pekmezci M, Tihan T, Bollen AW, Perry A, Shieh JTC, Solomon DA.

Brain Pathol. 2018 Jul 27. doi: 10.1111/bpa.12639. [Epub ahead of print]

PMID:
30051528
6.

Obituary. Charles B. Wilson, MD, 1929-2018.

Berger MS, Garner IV, McDermott MW.

J Neurosurg. 2018 Aug;129(2):547-550. doi: 10.3171/2018.5.JNS18974. Epub 2018 Jun 8. No abstract available.

PMID:
29882704
7.

Disparities in health care determine prognosis in newly diagnosed glioblastoma.

Chandra A, Rick JW, Dalle Ore C, Lau D, Nguyen AT, Carrera D, Bonte A, Molinaro AM, Theodosopoulos PV, McDermott MW, Berger MS, Aghi MK.

Neurosurg Focus. 2018 Jun;44(6):E16. doi: 10.3171/2018.3.FOCUS1852.

8.

Safety and outcomes of resection of butterfly glioblastoma.

Dayani F, Young JS, Bonte A, Chang EF, Theodosopoulos P, McDermott MW, Berger MS, Aghi MK.

Neurosurg Focus. 2018 Jun;44(6):E4. doi: 10.3171/2018.3.FOCUS1857.

PMID:
29852771
9.

Cost-effectiveness development for the postoperative care of craniotomy patients: a safe transitions pathway in neurological surgery.

Osorio JA, Safaee MM, Viner J, Sankaran S, Imershein S, Adigun E, Weigel G, Berger MS, McDermott MW.

Neurosurg Focus. 2018 May;44(5):E19. doi: 10.3171/2018.2.FOCUS1812.

PMID:
29712529
10.

The transcortical equatorial approach for gliomas of the mesial temporal lobe: techniques and functional outcomes.

Morshed RA, Young JS, Han SJ, Hervey-Jumper SL, Berger MS.

J Neurosurg. 2018 Apr 20:1-9. doi: 10.3171/2017.10.JNS172055. [Epub ahead of print]

PMID:
29676697
11.

Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin.

A D, Fadda P, G N, M F, A B, Mp G, Sacchi D, F C, M C, A A, Casini B, H K, E P, G DL, N Z, Ms B, Cm C.

EBioMedicine. 2018 Apr;30:105-112. doi: 10.1016/j.ebiom.2018.03.022. Epub 2018 Mar 21.

12.

Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approach.

Magill ST, Morshed RA, Lucas CG, Aghi MK, Theodosopoulos PV, Berger MS, de Divitiis O, Solari D, Cappabianca P, Cavallo LM, McDermott MW.

Neurosurg Focus. 2018 Apr;44(4):E9. doi: 10.3171/2018.1.FOCUS17753.

PMID:
29606045
13.

Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation.

Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY, Nicholaides T, Chang SM, Sneed PK, McDermott MW, Berger MS, Perry A, Raleigh DR.

Cell Rep. 2018 Mar 27;22(13):3672-3683. doi: 10.1016/j.celrep.2018.03.013.

14.

Postoperative Delirium in Glioblastoma Patients: Risk Factors and Prognostic Implications.

Flanigan PM, Jahangiri A, Weinstein D, Dayani F, Chandra A, Kanungo I, Choi S, Sankaran S, Molinaro AM, McDermott MW, Berger MS, Aghi MK.

Neurosurgery. 2018 Feb 16. doi: 10.1093/neuros/nyx606. [Epub ahead of print]

PMID:
29462362
15.

Region specific knock-out reveals distinct roles of chromatin modifiers in adult neurogenic niches.

Rhodes CT, Zunino G, Huang SA, Cardona SM, Cardona AE, Berger MS, Lemmon VP, Lin CA.

Cell Cycle. 2018;17(3):377-389. doi: 10.1080/15384101.2018.1426417. Epub 2018 Feb 19.

16.

Antisecretory Factor-Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma.

Ilkhanizadeh S, Sabelström H, Miroshnikova YA, Frantz A, Zhu W, Idilli A, Lakins JN, Schmidt C, Quigley DA, Fenster T, Yuan E, Trzeciak JR, Saxena S, Lindberg OR, Mouw JK, Burdick JA, Magnitsky S, Berger MS, Phillips JJ, Arosio D, Sun D, Weaver VM, Weiss WA, Persson AI.

Mol Cancer Res. 2018 May;16(5):777-790. doi: 10.1158/1541-7786.MCR-17-0413. Epub 2018 Feb 5.

PMID:
29431617
17.

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, Zheng S, Chang E, Gabriel Sauvé CE, Olar A, Lan ZD, Finocchiaro G, Phillips JJ, Berger MS, Gabrusiewicz KR, Wang G, Eskilsson E, Hu J, Mikkelsen T, DePinho RA, Muller F, Heimberger AB, Sulman EP, Nam DH, Verhaak RGW.

Cancer Cell. 2018 Jan 8;33(1):152. doi: 10.1016/j.ccell.2017.12.012. No abstract available.

18.

A cross-sectional study of neurosurgical department chairs in the United States.

Flanigan PM, Jahangiri A, Golubovsky JL, Karnuta JM, May FJ, Berger MS, Aghi MK.

J Neurosurg. 2018 Jan 5:1-7. doi: 10.3171/2017.7.JNS17567. [Epub ahead of print]

PMID:
29303441
19.

Resection of primary motor cortex tumors: feasibility and surgical outcomes.

Magill ST, Han SJ, Li J, Berger MS.

J Neurosurg. 2017 Dec 8:1-12. doi: 10.3171/2017.5.JNS163045. [Epub ahead of print]

PMID:
29219753
20.

Surgical oncology for gliomas: the state of the art.

Sanai N, Berger MS.

Nat Rev Clin Oncol. 2018 Feb;15(2):112-125. doi: 10.1038/nrclinonc.2017.171. Epub 2017 Nov 21. Review.

PMID:
29158591
21.

Seizure Outcome After Surgical Resection of Insular Glioma.

Wang DD, Deng H, Hervey-Jumper SL, Molinaro AA, Chang EF, Berger MS.

Neurosurgery. 2017 Nov 8. doi: 10.1093/neuros/nyx486. [Epub ahead of print]

PMID:
29126238
22.

Resection of gliomas deemed inoperable by neurosurgeons based on preoperative imaging studies.

Southwell DG, Birk HS, Han SJ, Li J, Sall JW, Berger MS.

J Neurosurg. 2018 Sep;129(3):567-575. doi: 10.3171/2017.5.JNS17166. Epub 2017 Nov 10.

PMID:
29125414
23.

Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma.

Byron SA, Tran NL, Halperin RF, Phillips JJ, Kuhn JG, de Groot JF, Colman H, Ligon KL, Wen PY, Cloughesy TF, Mellinghoff IK, Butowski NA, Taylor JW, Clarke JL, Chang SM, Berger MS, Molinaro AM, Maggiora GM, Peng S, Nasser S, Liang WS, Trent JM, Berens ME, Carpten JD, Craig DW, Prados MD.

Clin Cancer Res. 2018 Jan 15;24(2):295-305. doi: 10.1158/1078-0432.CCR-17-0963. Epub 2017 Oct 26.

PMID:
29074604
24.

Connected speech in transient aphasias after left hemisphere resective surgery.

McCarron A, Chavez A, Babiak M, Berger MS, Chang EF, Wilson SM.

Aphasiology. 2017;31(11):1266-1281. doi: 10.1080/02687038.2017.1278740. Epub 2017 Jan 17.

25.

In Reply: Neurosurgical Education in a Changing Healthcare and Regulatory Environment: A Consensus Statement From 6 Programs.

Kim DH, Dacey RG, Zipfel GJ, Berger MS, McDermott M, Barbaro NM, Shapiro SA, Solomon RA, Harbaugh R, Day AL.

Neurosurgery. 2017 Oct 1;81(4):E47. doi: 10.1093/neuros/nyx348. No abstract available.

PMID:
28934443
26.

Management of Elderly Patients with Glioblastoma after CE.6.

Das S, Kim AH, Chang S, Berger MS.

Front Oncol. 2017 Aug 30;7:196. doi: 10.3389/fonc.2017.00196. eCollection 2017. No abstract available.

27.

Changing Operating Room Culture: Implementation of a Postoperative Debrief and Improved Safety Culture.

Magill ST, Wang DD, Rutledge WC, Lau D, Berger MS, Sankaran S, Lau CY, Imershein SG.

World Neurosurg. 2017 Nov;107:597-603. doi: 10.1016/j.wneu.2017.08.090. Epub 2017 Aug 24.

PMID:
28843757
28.

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE.

Alexander BM, Ba S, Berger MS, Berry DA, Cavenee WK, Chang SM, Cloughesy TF, Jiang T, Khasraw M, Li W, Mittman R, Poste GH, Wen PY, Yung WKA, Barker AD; GBM AGILE Network.

Clin Cancer Res. 2018 Feb 15;24(4):737-743. doi: 10.1158/1078-0432.CCR-17-0764. Epub 2017 Aug 16. Review.

PMID:
28814435
29.

Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.

Lau D, Hervey-Jumper SL, Han SJ, Berger MS.

J Neurosurg. 2018 May;128(5):1410-1418. doi: 10.3171/2017.1.JNS161811. Epub 2017 Jul 21.

PMID:
28731401
30.

Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history.

Chan AK, Han SJ, Choy W, Beleford D, Aghi MK, Berger MS, Shieh JT, Bollen AW, Perry A, Phillips JJ, Butowski N, Solomon DA.

Clin Neuropathol. 2017 Sep/Oct;36(5):213-221. doi: 10.5414/NP301022.

31.

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, Zheng S, Chang E, Sauvé CG, Olar A, Lan ZD, Finocchiaro G, Phillips JJ, Berger MS, Gabrusiewicz KR, Wang G, Eskilsson E, Hu J, Mikkelsen T, DePinho RA, Muller F, Heimberger AB, Sulman EP, Nam DH, Verhaak RGW.

Cancer Cell. 2017 Jul 10;32(1):42-56.e6. doi: 10.1016/j.ccell.2017.06.003. Erratum in: Cancer Cell. 2018 Jan 8;33(1):152.

32.

Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note.

Morshed RA, Han SJ, Lau D, Berger MS.

J Neurosurg. 2018 May;128(5):1448-1453. doi: 10.3171/2017.1.JNS161949. Epub 2017 Jun 30.

PMID:
28665248
33.

Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure.

Flanigan PM, Jahangiri A, Kuang R, Truong A, Choi S, Chou A, Rick JW, Chang SM, Molinaro AM, McDermott MW, Berger MS, Aghi MK.

Neurosurgery. 2017 Nov 1;81(5):824-833. doi: 10.1093/neuros/nyx084.

PMID:
28541497
34.

Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma.

López G, Oberheim Bush NA, Berger MS, Perry A, Solomon DA.

Acta Neuropathol Commun. 2017 May 15;5(1):38. doi: 10.1186/s40478-017-0440-x. No abstract available.

35.

Developing an Algorithm for Optimizing Care of Elderly Patients With Glioblastoma.

Flanigan PM, Jahangiri A, Kuang R, Truong A, Choi S, Chou A, Molinaro AM, McDermott MW, Berger MS, Aghi MK.

Neurosurgery. 2018 Jan 1;82(1):64-75. doi: 10.1093/neuros/nyx148.

PMID:
28475720
36.

Analysis of Cost Variation in Craniotomy for Tumor Using 2 National Databases.

Zygourakis CC, Liu CY, Yoon S, Moriates C, Boscardin C, Dudley RA, Lawton MT, Theodosopoulos P, Berger MS, Gonzales R.

Neurosurgery. 2017 Dec 1;81(6):972-979. doi: 10.1093/neuros/nyx133.

PMID:
28402457
37.

A Review and Survey of Neurosurgeon-Hospital Relationships: Evolution and Options.

Kim DH, Duco B, Wolterman D, Stokes C, Brace R, Solomon RA, Barbaro N, Westmark R, MacDougall D, Bean J, O'Leary J, Moayeri N, Dacey RG Jr, Berger MS, Harbaugh R.

Neurosurgery. 2017 Apr 1;80(4S):S10-S18. doi: 10.1093/neuros/nyw171. Review.

PMID:
28375496
38.

Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma.

Jalbert LE, Elkhaled A, Phillips JJ, Neill E, Williams A, Crane JC, Olson MP, Molinaro AM, Berger MS, Kurhanewicz J, Ronen SM, Chang SM, Nelson SJ.

Sci Rep. 2017 Mar 22;7:44792. doi: 10.1038/srep44792.

39.

Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.

Lin CA, Rhodes CT, Lin C, Phillips JJ, Berger MS.

Cell Cycle. 2017 Apr 18;16(8):765-775. doi: 10.1080/15384101.2017.1295186. Epub 2017 Feb 22.

40.

Foreword.

Berger MS.

Neurochirurgie. 2017 Jun;63(3):113-114. doi: 10.1016/j.neuchi.2016.05.003. Epub 2016 Oct 26. No abstract available.

PMID:
28277279
41.

Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.

Pekmezci M, Rice T, Molinaro AM, Walsh KM, Decker PA, Hansen H, Sicotte H, Kollmeyer TM, McCoy LS, Sarkar G, Perry A, Giannini C, Tihan T, Berger MS, Wiemels JL, Bracci PM, Eckel-Passow JE, Lachance DH, Clarke J, Taylor JW, Luks T, Wiencke JK, Jenkins RB, Wrensch MR.

Acta Neuropathol. 2017 Jun;133(6):1001-1016. doi: 10.1007/s00401-017-1690-1. Epub 2017 Mar 2.

42.

Neurosurgical Education in a Changing Healthcare and Regulatory Environment: A Consensus Statement from 6 Programs.

Kim DH, Dacey RG, Zipfel GJ, Berger MS, McDermott M, Barbaro NM, Shapiro SA, Solomon RA, Harbaugh R, Day AL.

Neurosurgery. 2017 Apr 1;80(4S):S75-S82. doi: 10.1093/neuros/nyw146.

PMID:
28204661
43.

Anesthesia for awake craniotomy: a how-to guide for the occasional practitioner.

Meng L, McDonagh DL, Berger MS, Gelb AW.

Can J Anaesth. 2017 May;64(5):517-529. doi: 10.1007/s12630-017-0840-1. Epub 2017 Feb 8. Review.

PMID:
28181184
44.

Language outcomes after resection of dominant inferior parietal lobule gliomas.

Southwell DG, Riva M, Jordan K, Caverzasi E, Li J, Perry DW, Henry RG, Berger MS.

J Neurosurg. 2017 Oct;127(4):781-789. doi: 10.3171/2016.8.JNS16443. Epub 2017 Jan 6.

PMID:
28059657
45.

Erratum to: Surgical resection of fourth ventricular ependymomas: case series and technical nuances.

Winkler EA, Birk H, Safaee M, Yue JK, Burke JF, Viner JA, Pekmezci M, Perry A, Aghi MK, Berger MS, McDermott MW.

J Neurooncol. 2017 Jan;131(2):423. doi: 10.1007/s11060-016-2343-2. No abstract available.

PMID:
28039568
46.

Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth.

Hu B, Wang Q, Wang YA, Hua S, Sauvé CG, Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, Lu X, Zhong Y, Zhang J, Deng P, Tan Z, Wang G, Liao WT, Corley LJ, Yan H, Zhang J, You Y, Liu N, Cai L, Finocchiaro G, Phillips JJ, Berger MS, Spring DJ, Hu J, Sulman EP, Fuller GN, Chin L, Verhaak RGW, DePinho RA.

Cell. 2016 Nov 17;167(5):1281-1295.e18. doi: 10.1016/j.cell.2016.10.039.

47.

Surgical resection of fourth ventricular ependymomas: case series and technical nuances.

Winkler EA, Birk H, Safaee M, Yue JK, Burke JF, Viner JA, Pekmezci M, Perry A, Aghi MK, Berger MS, McDermott MW.

J Neurooncol. 2016 Nov;130(2):341-349. Epub 2016 Oct 24. Review. Erratum in: J Neurooncol. 2017 Jan;131(2):423.

PMID:
27778210
48.

The transsylvian approach for resection of insular gliomas: technical nuances of splitting the Sylvian fissure.

Safaee MM, Englot DJ, Han SJ, Lawton MT, Berger MS.

J Neurooncol. 2016 Nov;130(2):283-287. Epub 2016 Jun 13. Review.

PMID:
27294356
49.

BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas.

Olow A, Mueller S, Yang X, Hashizume R, Meyerowitz J, Weiss W, Resnick AC, Waanders AJ, Stalpers LJ, Berger MS, Gupta N, James CD, Petritsch CK, Haas-Kogan DA.

Clin Cancer Res. 2016 Nov 1;22(21):5312-5321. Epub 2016 May 23.

50.

Maximizing safe resection of low- and high-grade glioma.

Hervey-Jumper SL, Berger MS.

J Neurooncol. 2016 Nov;130(2):269-282. Epub 2016 May 12. Review.

PMID:
27174197

Supplemental Content

Loading ...
Support Center